COMP <GO>
THC vs HCA // DIVIDEND YIELD & FCF PAYOUT SAFETY
Tenet Healthcare Corporation (NYSE) VS. HCA Healthcare Inc. (NYSE) • 15-METRIC TALLY: THC 6
— HCA 7
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: HCA
LAST: $273.25 (+0.99%) • MKT CAP: $21.79B
dividend-safety
0.00%
LAST: $473.19 (-1.02%) • MKT CAP: $103.51B
dividend-safety
0.66%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (THC VS. HCA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | THC | HCA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 27.60% | 18.90% | +8.70 | THC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.3x | 11.5x | -5.20 | THC | /valuation <GO> |
| Free Cash Flow Yield | 11.61% | 7.43% | +4.18 | THC | /fcf-yield <GO> |
| Operating Margin | 16.50% | 10.90% | +5.60 | THC | /operating-margins <GO> |
| Net Profit Margin | 11.10% | 9.00% | +2.10 | THC | /net-margins <GO> |
| Revenue Growth (YoY) | 3.10% | 7.10% | -4.00 | HCA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.66% | -0.66 | HCA | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.08 | 3.68 | -1.60 | HCA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | HCA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 54.8 | 62.6 | -7.80 | HCA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.97 | 1.04 | -0.07 | HCA | /macro-sensitivity <GO> |
| Forward P/E Multiple | 8.6x | 14.2x | -5.60 | THC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $21.79B | $103.51B | -$81.72B | HCA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | THC REV | HCA REV | THC GROSS % | HCA GROSS % | THC FCF | HCA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $21.31B | $75.60B | — | — | $2.53B | $7.69B |
| FY 2024 | $20.68B | $70.60B | — | — | $1.12B | $5.64B |
| FY 2023 | $20.56B | $64.97B | — | — | $1.45B | $6.51B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
THC // BETA 0.97
HCA // BETA 1.04